[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Companion Animal Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

July 2024 | 111 pages | ID: GB05A3AA59D6EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Companion Animal Drugs market size was valued at USD 27550 million in 2023 and is forecast to a readjusted size of USD 33150 million by 2030 with a CAGR of 2.7% during review period.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 24%.

The Global Info Research report includes an overview of the development of the Companion Animal Drugs industry chain, the market status of Dogs (Antibiotics and Antimicrobials, Parasiticides), Cats (Antibiotics and Antimicrobials, Parasiticides), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Companion Animal Drugs.

Regionally, the report analyzes the Companion Animal Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Companion Animal Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Companion Animal Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Companion Animal Drugs industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Antibiotics and Antimicrobials, Parasiticides).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Companion Animal Drugs market.

Regional Analysis: The report involves examining the Companion Animal Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Companion Animal Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Companion Animal Drugs:

Company Analysis: Report covers individual Companion Animal Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Companion Animal Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Dogs, Cats).

Technology Analysis: Report covers specific technologies relevant to Companion Animal Drugs. It assesses the current state, advancements, and potential future developments in Companion Animal Drugs areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Companion Animal Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Companion Animal Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
  • Antibiotics and Antimicrobials
  • Parasiticides
  • Others
Market segment by Application
  • Dogs
  • Cats
  • Horses
  • Others
Market segment by players, this report covers
  • Zoetis
  • Bayer
  • Boehringer Ingelheim
  • Eli Lilly
  • Merck
  • Vetoquinol
  • Virbac
  • Dechra Pharmaceuticals
  • Ceva Sante Animale
  • Aratana Therapeutics
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Companion Animal Drugs product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Companion Animal Drugs, with revenue, gross margin and global market share of Companion Animal Drugs from 2019 to 2024.

Chapter 3, the Companion Animal Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Companion Animal Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Animal Drugs.

Chapter 13, to describe Companion Animal Drugs research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Companion Animal Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Companion Animal Drugs by Type
  1.3.1 Overview: Global Companion Animal Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
  1.3.2 Global Companion Animal Drugs Consumption Value Market Share by Type in 2023
  1.3.3 Antibiotics and Antimicrobials
  1.3.4 Parasiticides
  1.3.5 Others
1.4 Global Companion Animal Drugs Market by Application
  1.4.1 Overview: Global Companion Animal Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Dogs
  1.4.3 Cats
  1.4.4 Horses
  1.4.5 Others
1.5 Global Companion Animal Drugs Market Size & Forecast
1.6 Global Companion Animal Drugs Market Size and Forecast by Region
  1.6.1 Global Companion Animal Drugs Market Size by Region: 2019 VS 2023 VS 2030
  1.6.2 Global Companion Animal Drugs Market Size by Region, (2019-2030)
  1.6.3 North America Companion Animal Drugs Market Size and Prospect (2019-2030)
  1.6.4 Europe Companion Animal Drugs Market Size and Prospect (2019-2030)
  1.6.5 Asia-Pacific Companion Animal Drugs Market Size and Prospect (2019-2030)
  1.6.6 South America Companion Animal Drugs Market Size and Prospect (2019-2030)
  1.6.7 Middle East and Africa Companion Animal Drugs Market Size and Prospect (2019-2030)

2 COMPANY PROFILES

2.1 Zoetis
  2.1.1 Zoetis Details
  2.1.2 Zoetis Major Business
  2.1.3 Zoetis Companion Animal Drugs Product and Solutions
  2.1.4 Zoetis Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 Zoetis Recent Developments and Future Plans
2.2 Bayer
  2.2.1 Bayer Details
  2.2.2 Bayer Major Business
  2.2.3 Bayer Companion Animal Drugs Product and Solutions
  2.2.4 Bayer Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 Bayer Recent Developments and Future Plans
2.3 Boehringer Ingelheim
  2.3.1 Boehringer Ingelheim Details
  2.3.2 Boehringer Ingelheim Major Business
  2.3.3 Boehringer Ingelheim Companion Animal Drugs Product and Solutions
  2.3.4 Boehringer Ingelheim Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
2.4 Eli Lilly
  2.4.1 Eli Lilly Details
  2.4.2 Eli Lilly Major Business
  2.4.3 Eli Lilly Companion Animal Drugs Product and Solutions
  2.4.4 Eli Lilly Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 Eli Lilly Recent Developments and Future Plans
2.5 Merck
  2.5.1 Merck Details
  2.5.2 Merck Major Business
  2.5.3 Merck Companion Animal Drugs Product and Solutions
  2.5.4 Merck Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 Merck Recent Developments and Future Plans
2.6 Vetoquinol
  2.6.1 Vetoquinol Details
  2.6.2 Vetoquinol Major Business
  2.6.3 Vetoquinol Companion Animal Drugs Product and Solutions
  2.6.4 Vetoquinol Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 Vetoquinol Recent Developments and Future Plans
2.7 Virbac
  2.7.1 Virbac Details
  2.7.2 Virbac Major Business
  2.7.3 Virbac Companion Animal Drugs Product and Solutions
  2.7.4 Virbac Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Virbac Recent Developments and Future Plans
2.8 Dechra Pharmaceuticals
  2.8.1 Dechra Pharmaceuticals Details
  2.8.2 Dechra Pharmaceuticals Major Business
  2.8.3 Dechra Pharmaceuticals Companion Animal Drugs Product and Solutions
  2.8.4 Dechra Pharmaceuticals Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 Dechra Pharmaceuticals Recent Developments and Future Plans
2.9 Ceva Sante Animale
  2.9.1 Ceva Sante Animale Details
  2.9.2 Ceva Sante Animale Major Business
  2.9.3 Ceva Sante Animale Companion Animal Drugs Product and Solutions
  2.9.4 Ceva Sante Animale Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2024)
  2.9.5 Ceva Sante Animale Recent Developments and Future Plans
2.10 Aratana Therapeutics
  2.10.1 Aratana Therapeutics Details
  2.10.2 Aratana Therapeutics Major Business
  2.10.3 Aratana Therapeutics Companion Animal Drugs Product and Solutions
  2.10.4 Aratana Therapeutics Companion Animal Drugs Revenue, Gross Margin and Market Share (2019-2024)
  2.10.5 Aratana Therapeutics Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Companion Animal Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
  3.2.1 Market Share of Companion Animal Drugs by Company Revenue
  3.2.2 Top 3 Companion Animal Drugs Players Market Share in 2023
  3.2.3 Top 6 Companion Animal Drugs Players Market Share in 2023
3.3 Companion Animal Drugs Market: Overall Company Footprint Analysis
  3.3.1 Companion Animal Drugs Market: Region Footprint
  3.3.2 Companion Animal Drugs Market: Company Product Type Footprint
  3.3.3 Companion Animal Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Companion Animal Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global Companion Animal Drugs Market Forecast by Type (2025-2030)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Companion Animal Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global Companion Animal Drugs Market Forecast by Application (2025-2030)

6 NORTH AMERICA

6.1 North America Companion Animal Drugs Consumption Value by Type (2019-2030)
6.2 North America Companion Animal Drugs Consumption Value by Application (2019-2030)
6.3 North America Companion Animal Drugs Market Size by Country
  6.3.1 North America Companion Animal Drugs Consumption Value by Country (2019-2030)
  6.3.2 United States Companion Animal Drugs Market Size and Forecast (2019-2030)
  6.3.3 Canada Companion Animal Drugs Market Size and Forecast (2019-2030)
  6.3.4 Mexico Companion Animal Drugs Market Size and Forecast (2019-2030)

7 EUROPE

7.1 Europe Companion Animal Drugs Consumption Value by Type (2019-2030)
7.2 Europe Companion Animal Drugs Consumption Value by Application (2019-2030)
7.3 Europe Companion Animal Drugs Market Size by Country
  7.3.1 Europe Companion Animal Drugs Consumption Value by Country (2019-2030)
  7.3.2 Germany Companion Animal Drugs Market Size and Forecast (2019-2030)
  7.3.3 France Companion Animal Drugs Market Size and Forecast (2019-2030)
  7.3.4 United Kingdom Companion Animal Drugs Market Size and Forecast (2019-2030)
  7.3.5 Russia Companion Animal Drugs Market Size and Forecast (2019-2030)
  7.3.6 Italy Companion Animal Drugs Market Size and Forecast (2019-2030)

8 ASIA-PACIFIC

8.1 Asia-Pacific Companion Animal Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Companion Animal Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Companion Animal Drugs Market Size by Region
  8.3.1 Asia-Pacific Companion Animal Drugs Consumption Value by Region (2019-2030)
  8.3.2 China Companion Animal Drugs Market Size and Forecast (2019-2030)
  8.3.3 Japan Companion Animal Drugs Market Size and Forecast (2019-2030)
  8.3.4 South Korea Companion Animal Drugs Market Size and Forecast (2019-2030)
  8.3.5 India Companion Animal Drugs Market Size and Forecast (2019-2030)
  8.3.6 Southeast Asia Companion Animal Drugs Market Size and Forecast (2019-2030)
  8.3.7 Australia Companion Animal Drugs Market Size and Forecast (2019-2030)

9 SOUTH AMERICA

9.1 South America Companion Animal Drugs Consumption Value by Type (2019-2030)
9.2 South America Companion Animal Drugs Consumption Value by Application (2019-2030)
9.3 South America Companion Animal Drugs Market Size by Country
  9.3.1 South America Companion Animal Drugs Consumption Value by Country (2019-2030)
  9.3.2 Brazil Companion Animal Drugs Market Size and Forecast (2019-2030)
  9.3.3 Argentina Companion Animal Drugs Market Size and Forecast (2019-2030)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Companion Animal Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Companion Animal Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Companion Animal Drugs Market Size by Country
  10.3.1 Middle East & Africa Companion Animal Drugs Consumption Value by Country (2019-2030)
  10.3.2 Turkey Companion Animal Drugs Market Size and Forecast (2019-2030)
  10.3.3 Saudi Arabia Companion Animal Drugs Market Size and Forecast (2019-2030)
  10.3.4 UAE Companion Animal Drugs Market Size and Forecast (2019-2030)

11 MARKET DYNAMICS

11.1 Companion Animal Drugs Market Drivers
11.2 Companion Animal Drugs Market Restraints
11.3 Companion Animal Drugs Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Companion Animal Drugs Industry Chain
12.2 Companion Animal Drugs Upstream Analysis
12.3 Companion Animal Drugs Midstream Analysis
12.4 Companion Animal Drugs Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

LIST OF TABLES

Table 1. Global Companion Animal Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Companion Animal Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Companion Animal Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Companion Animal Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Zoetis Company Information, Head Office, and Major Competitors
Table 6. Zoetis Major Business
Table 7. Zoetis Companion Animal Drugs Product and Solutions
Table 8. Zoetis Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Zoetis Recent Developments and Future Plans
Table 10. Bayer Company Information, Head Office, and Major Competitors
Table 11. Bayer Major Business
Table 12. Bayer Companion Animal Drugs Product and Solutions
Table 13. Bayer Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Bayer Recent Developments and Future Plans
Table 15. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 16. Boehringer Ingelheim Major Business
Table 17. Boehringer Ingelheim Companion Animal Drugs Product and Solutions
Table 18. Boehringer Ingelheim Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Boehringer Ingelheim Recent Developments and Future Plans
Table 20. Eli Lilly Company Information, Head Office, and Major Competitors
Table 21. Eli Lilly Major Business
Table 22. Eli Lilly Companion Animal Drugs Product and Solutions
Table 23. Eli Lilly Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Eli Lilly Recent Developments and Future Plans
Table 25. Merck Company Information, Head Office, and Major Competitors
Table 26. Merck Major Business
Table 27. Merck Companion Animal Drugs Product and Solutions
Table 28. Merck Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Merck Recent Developments and Future Plans
Table 30. Vetoquinol Company Information, Head Office, and Major Competitors
Table 31. Vetoquinol Major Business
Table 32. Vetoquinol Companion Animal Drugs Product and Solutions
Table 33. Vetoquinol Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Vetoquinol Recent Developments and Future Plans
Table 35. Virbac Company Information, Head Office, and Major Competitors
Table 36. Virbac Major Business
Table 37. Virbac Companion Animal Drugs Product and Solutions
Table 38. Virbac Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Virbac Recent Developments and Future Plans
Table 40. Dechra Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 41. Dechra Pharmaceuticals Major Business
Table 42. Dechra Pharmaceuticals Companion Animal Drugs Product and Solutions
Table 43. Dechra Pharmaceuticals Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Dechra Pharmaceuticals Recent Developments and Future Plans
Table 45. Ceva Sante Animale Company Information, Head Office, and Major Competitors
Table 46. Ceva Sante Animale Major Business
Table 47. Ceva Sante Animale Companion Animal Drugs Product and Solutions
Table 48. Ceva Sante Animale Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Ceva Sante Animale Recent Developments and Future Plans
Table 50. Aratana Therapeutics Company Information, Head Office, and Major Competitors
Table 51. Aratana Therapeutics Major Business
Table 52. Aratana Therapeutics Companion Animal Drugs Product and Solutions
Table 53. Aratana Therapeutics Companion Animal Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Aratana Therapeutics Recent Developments and Future Plans
Table 55. Global Companion Animal Drugs Revenue (USD Million) by Players (2019-2024)
Table 56. Global Companion Animal Drugs Revenue Share by Players (2019-2024)
Table 57. Breakdown of Companion Animal Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Companion Animal Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Companion Animal Drugs Players
Table 60. Companion Animal Drugs Market: Company Product Type Footprint
Table 61. Companion Animal Drugs Market: Company Product Application Footprint
Table 62. Companion Animal Drugs New Market Entrants and Barriers to Market Entry
Table 63. Companion Animal Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Companion Animal Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Companion Animal Drugs Consumption Value Share by Type (2019-2024)
Table 66. Global Companion Animal Drugs Consumption Value Forecast by Type (2025-2030)
Table 67. Global Companion Animal Drugs Consumption Value by Application (2019-2024)
Table 68. Global Companion Animal Drugs Consumption Value Forecast by Application (2025-2030)
Table 69. North America Companion Animal Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Companion Animal Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Companion Animal Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Companion Animal Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Companion Animal Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Companion Animal Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Companion Animal Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Companion Animal Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Companion Animal Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Companion Animal Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Companion Animal Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Companion Animal Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Companion Animal Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Companion Animal Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Companion Animal Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Companion Animal Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Companion Animal Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Companion Animal Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Companion Animal Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Companion Animal Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Companion Animal Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Companion Animal Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Companion Animal Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Companion Animal Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Companion Animal Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Companion Animal Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Companion Animal Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Companion Animal Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Companion Animal Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Companion Animal Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Companion Animal Drugs Raw Material
Table 100. Key Suppliers of Companion Animal Drugs Raw Materials

LIST OF FIGURES

Figure 1. Companion Animal Drugs Picture
Figure 2. Global Companion Animal Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Companion Animal Drugs Consumption Value Market Share by Type in 2023
Figure 4. Antibiotics and Antimicrobials
Figure 5. Parasiticides
Figure 6. Others
Figure 7. Global Companion Animal Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Companion Animal Drugs Consumption Value Market Share by Application in 2023
Figure 9. Dogs Picture
Figure 10. Cats Picture
Figure 11. Horses Picture
Figure 12. Others Picture
Figure 13. Global Companion Animal Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Companion Animal Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Companion Animal Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Companion Animal Drugs Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Companion Animal Drugs Consumption Value Market Share by Region in 2023
Figure 18. North America Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Companion Animal Drugs Revenue Share by Players in 2023
Figure 24. Companion Animal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Companion Animal Drugs Market Share in 2023
Figure 26. Global Top 6 Players Companion Animal Drugs Market Share in 2023
Figure 27. Global Companion Animal Drugs Consumption Value Share by Type (2019-2024)
Figure 28. Global Companion Animal Drugs Market Share Forecast by Type (2025-2030)
Figure 29. Global Companion Animal Drugs Consumption Value Share by Application (2019-2024)
Figure 30. Global Companion Animal Drugs Market Share Forecast by Application (2025-2030)
Figure 31. North America Companion Animal Drugs Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Companion Animal Drugs Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Companion Animal Drugs Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Companion Animal Drugs Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Companion Animal Drugs Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Companion Animal Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. France Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Companion Animal Drugs Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Companion Animal Drugs Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Companion Animal Drugs Consumption Value Market Share by Region (2019-2030)
Figure 48. China Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. India Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Companion Animal Drugs Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Companion Animal Drugs Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Companion Animal Drugs Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Companion Animal Drugs Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Companion Animal Drugs Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Companion Animal Drugs Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Companion Animal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 65. Companion Animal Drugs Market Drivers
Figure 66. Companion Animal Drugs Market Restraints
Figure 67. Companion Animal Drugs Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Companion Animal Drugs in 2023
Figure 70. Manufacturing Process Analysis of Companion Animal Drugs
Figure 71. Companion Animal Drugs Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source


More Publications